Share Name Share Symbol Market Type Share ISIN Share Description
Smithson Investment Trust Plc LSE:SSON London Ordinary Share GB00BGJWTR88 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  12.00 0.75% 1,604.00 597,026 16:35:27
Bid Price Offer Price High Price Low Price Open Price
1,602.00 1,606.00 1,616.00 1,600.00 1,600.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 15.55 1.65 0.26 6,169.2 2,130
Last Trade Time Trade Type Trade Size Trade Price Currency
16:35:27 UT 36,285 1,604.00 GBX

Smithson Investment (SSON) Latest News (2)

More Smithson Investment News
Smithson Investment Investors    Smithson Investment Takeover Rumours

Smithson Investment (SSON) Discussions and Chat

Smithson Investment Forums and Chat

Date Time Title Posts
04/11/202013:45Smithson Investment Trust206

Add a New Thread

Smithson Investment (SSON) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2020-12-01 16:35:271,604.0036,285582,011.40UT
2020-12-01 16:29:311,602.002253,604.50AT
2020-12-01 16:29:311,606.00631,011.78AT
2020-12-01 16:29:181,606.002213,549.26AT
2020-12-01 16:28:061,606.003104,978.60O
View all Smithson Investment trades in real-time

Smithson Investment (SSON) Top Chat Posts

Smithson Investment Daily Update: Smithson Investment Trust Plc is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker SSON. The last closing price for Smithson Investment was 1,592p.
Smithson Investment Trust Plc has a 4 week average price of 1,494p and a 12 week average price of 1,454p.
The 1 year high share price is 1,638p while the 1 year low share price is currently 890p.
There are currently 132,790,958 shares in issue and the average daily traded volume is 524,146 shares. The market capitalisation of Smithson Investment Trust Plc is £2,129,966,966.32.
bezer: Mdumont: like you, I hold a lot in Fundsmith and Smithson and I am loving it! For the record I am now looking to build up on Blue Whale Growth (I know it is similar to Fundsmith) because no matter how much I love Fundsmith & Smithson, there is only so much of a good thing I can take! If truth be known everybody got it wrong at inception time for Smithson. There were quite a few people who did not like the Investment Trust format and were spooked by the disappointing performance of FEET. I thought that Smithson was going to be a winner as soon as I saw it but did anybody envisage over 57% in two years?! I think not. The NAV hit an all time high this morning at +3.9% and the share price is currently +3% for October alone. At inception time the back testing suggested that Smithson should outperform the mighty main Fundsmith Equity fund and so has! Oh long may this continue!
bezer: The Smithson Share price has just hit a new record this morning and is now +20% YTD. I know a lot of Smithson is in the US but it is worth pointing out that the FTSE is -21.5% YTD. Surely no one predicted how successful this wonderful Investment Trust would be when it was launched just under two years ago?......
bezer: Agreed Juggler. It is EVEN more impressive when you examine the latest Smithson Factsheet. From inception (19th October 2018)to 30th April 2020 Smithson Share price did 31.0%. However, during the same period their benchmark index did -4.7%. Check the numbers - it's true! During the launch of Smithson, back testing suggested it 'should' better the main fund - a tough task. So has. Also watch the new investment - Qualys inc.
mozy123: Never mentioned Nike before at an AGM. Mastercard, agree he likes it but portfolio already full with that industry. Starbucks - never mentioned that one, but the china comment made me think of it. Lukin coffee also had a fraud "glitch" haha!! Clorox - he started buying, but then covid hit and the share price ran away, and so wasnt able to buy for the fund a full position. Hes often said that if he cant buy a full position then it will be sold. In any event a nice trade, and no his strat hasnt changed, he just couldnt buy any more due to price. Nike and Starbucks are class companies.
hectorscrackhouse: Main fund: ""During the month we sold our position in Clorox, the US producer of household, cleaning and personal care products, whose share price has performed strongly since purchase due to the current crisis, which has produced other investment opportunities we wish to take advantage of. The top 5 contributors in the month were Paypal, Microsoft, Facebook, Stryker and Intuit. The top 5 detractors were Amadeus, an as yet undisclosed new position, Waters, Intertek and Clorox."" Well, he bought Church and Dwight last year and sold it after a couple of months to buy Clorox and now he has binned Clorox after 6/12 or so. Bit of churn going on Terry. Meanwhile Clorox continues to rocket in the current crisis. Bit weird. No mention of the two new holdings yet.
bezer: As we go into this Easter Weekend, we have the "scores on the doors". Since Jan 1st 2020 YTD: Fundsmith T Class Equity -5.09%. Smithson Investment Trust -5.39%. In this year from hell?! LOADS of luck - I managed to top up on Smithson at below inception price on March 20th. Very fortunate. I wonder if I have joined the ELITE, not only was I an original Smithson Investor, I can add I bought just north of £20K at below inception price - £9.58. Very, very lucky. Be safe people.
basstrend: Yes the SSON share price got clobbered, along with the global markets in general. This is down to general panic and hysteria over the coronavirus of course. Some might argue that some stocks were getting a 'bit toppy' too so maybe some form of correction was due at some point. I'm not sure about that. I hold six investment trusts in my SIPP, including SSON and they all took a severe bashing last week. In just one week the average drop was 17%, which is quite a bit higher than the global markets dropped in the last week. Not sure I understand why ITs suffered worse (other than travel related stocks) compared to other stocks and indices.. Anyway, here's the drop I observed on the 6 trusts mentioned above, in the last 5 market days only - 18.95% ATT - Allianz Technology Trust 18.28% THRG - BlackRock Throgmorton Trust 18.85% MNL - Manchester & London Inv Trust 14.86% PCT - Polar Capital Trust 13.69% SMT - Scottish Mortgage Trust 17.39% SSON - Smithson Inv Trust NB the average 5 day drop across these 6 IT's is: 17% - quite shocking really!
spacecake: FEET pain a small dividend. Anyway the share price got well and truly clobbered this week, coronavirus panic or something in the results ?
wirralowl: Can anyone confirm if we're ever likely to receive dividends from SSON? I can't put my finger on it, but have in mind that we'd receive a small annual payout from SSON, of a similar level to the payment received from Fundsmith? TIA.
lomax99: Added a few around £12.07, profiled in Shares this week:Smithson lives up to the hype as the Fundsmith trust turns oneWe explore how it has achieved nearly 19% return in 12 months A year ago Smithson (SSON) became the largest ever investment trust launch, raising £822.5m to invest in quality small to mid-cap companies. Investors lapped up the shares in the hope they would deliver similar success to its sister fund, Fundsmith Equity (B41YBW7).Their faith has been rewarded with Smithson having achieved 18.8% return since launch on 19 October 2018 versus 19.7% from the flagship Fundsmith fund over the same period.This great start will have certainly been helped by the timing of Smithson's launch which happened during a weak period for the stock market, thus valuations were lower for many companies. That's advantageous when trying to build a portfolio.A good start will boost sentiment towards the trust but it will take several more years before you can truly start to judge its performance.Smithson's top holdingsAmong the top holdings is Verisk Analytics, a data provider for the insurance and natural resources industries. It has the world's largest database of insurance claims information. 'When you are doing anything in insurance – writing a contract, managing your claims, doing fraud detection – data is absolutely key,' says Morgan.Https://'Insurance companies buy the data from Verisk and generally do so via long-term subscription contracts. If an insurer goes to buy data from Verisk, they first have to also give them all their data.'The bigger the data pool the better, so as they grow the barriers to entry keep getting bigger, like a network effect.'FUNDSMITH EXTENSIONSmithson was created to take advantage of good companies that would be too small for Fundsmith Equity as the latter focuses on very large businesses. A team was assembled and they spent a year writing approximately 150 reports on stocks that matched the same criteria used for Fundsmith Equity, namely a focus on aspects such as free cash flow.Many of these potential companies were subsequently rejected, leaving a much smaller investable universe which currently stands as 77 stocks. Of this universe, Smithson currently has positions in 29 companies.A focus on quality is interesting as investors have been prepared to pay high multiples for seemingly top-notch businesses for many years on the stock market. Late August this year saw a sudden rotation where investors switched to buying value stocks, namely companies on very cheap valuations.So far it looks like this could be a short-term switch. But if quality did go out of favour, it would arguably also leave Smithson out of favour given its quality focus.Portfolio manager Simon Barnard insists such an event wouldn't prompt him to change his style as he believes any shifts in the market are 'irrelevant'. He comments: 'Our strategy is fairly clear – buy good companies, don't overpay, do nothing.'Sometimes the market throws up opportunities, sometimes it doesn't. We aren't aiming to outperform in every period, we are aiming to outperform in the long term. It would seem crazy to change a long term strategy that works for a short term change in the market.'THE VALUATION DEBATEBarnard says he is looking for value, just not really cheap and potentially inferior businesses. The fund manager says he often gets asks by investors why he has invested in what look like very expensive companies such as Halma (HLMA) and Rightmove (RMV). His answer is that investors may be looking at the wrong valuation metric.'We focus on free cash flow yield. Rightmove generates a lot of free cash flow; when you look at it on that metric it is not that expensive compared to other things on the market.'Assistant portfolio manager Will Morgan says at Smithson's half year stage (30 June 2019), the portfolio valuation was the same as the reference market which is the MSCI World Small and Mid-Cap index. 'We think we are getting at the same price much higher quality businesses that also grow about 1.5 times the rate of companies in the reference index,' he comments.'If you were to look at the portfolio on aggregate, our companies on average have nearly four times the return on capital employed of the reference market. They tend to have much higher operating margins, significantly higher cash generation and much lower leverage so we can be fairly confident that the quality of the businesses we own are significantly ahead of that in the market.'Even though the headline multiples might appear high to some, there is a difference between being highly rated and being expensive.'TERRY SMITH'S ROLEThe tremendous success of Fundsmith Equity – which has delivered 18.6% annualised returns since launch in November 2010 – means that Smithson's fund managers were under pressure from day one to deliver equally strong returns. In particular, there was also the fact that Fundsmith Equity's architect and fund manager Terry Smith wouldn't be running Smithson.'Expectations are high internally and externally,' admits Barnard. 'Ultimately all we care about is the performance.'At the end of the day we are investing people's life savings. The fact that we get to meet a lot of our investors helps to remind us of that – it is very motivating. We are very focused on executing the strategy to the best of our ability.'Investors may find some comfort that Smith is still closely involved with Smithson despite not being behind the wheel. 'Day to day we just get on with it. On big issues like selling a position outright or making an investment in a company for the first time, we would always consult him in his role as Fundsmith's chief investment officer, but I as portfolio manager make the final decision,' clarifies Barnard.Dealing with portfolio detractorsSmithson's performance is really impressive but like all funds there are weak spots. It recently sold US auto industry software provider CDK Global after a change in management and strategy left the fund managers lacking confidence in the firm.The investment trust has also had to stomach recent share price weakness in Ambu which makes disposable endoscopes. 'So far the market has been reusable ones, but the problem is that they are expensive to buy in the first place and very expensive to clean. There is also a risk that the cleaning process is not adequate and therefore a high risk of contamination,' explains Morgan.He says Ambu has developed a disposable endoscope which at the moment costs the same as it would do to clean a reusable one, with the added benefit of removing the risk and liability of contamination.'It is in fairly early stage of what we expect to be long term growth. Ambu has had issues with timing of product launches and a change in CEO which has led to concerns that the long term market opportunity is not as big as people once thought. But we believe the opportunity is as big.'BROAD EXPERTISEBoth Barnard and Morgan joined from investment bank Goldman Sachs where the former was a fund manager and the latter an analyst. They were recruited to launch Smithson, alongside Fundsmith analyst Jonathan Imlah, due to their expertise.Combined they have covered many different sectors which is handy as Smithson doesn't have a specific sector or geographic market focus.For example, they are comfortable analysing and investing in Spirax-Sarco (SPX), a UK steam engineer. 'Steam is used in the manufacture of almost any product you care to imagine,' says Morgan. 'Spirax has a highly skilled salesforce who are highly qualified engineers and who are embedded in their customers' businesses.'The fact Smithson's investable universe is only 77 stocks at present means the fund managers can focus on those businesses and read large amounts of relevant material. 'Warren Buffett famously said you only need moderate intelligence to understand all of this; you just don't want to be making mistakes,' says Barnard. 'These are not complicated businesses (in the portfolio).'It also helps that its portfolio companies are at a mature enough stage so the managers can have comfort in their business models. 'These are companies which are highly profitable and have good track records,' remarks Morgan. 'The numbers tell you something.'If we were looking at speculative businesses or speculative technology, pre-revenue or pre-profit, then we might need some expertise to guess if the thing is going to work. That isn't a game we are going to play. We are looking at companies that have already won.'SHARES SAYS: Smithson is certainly delivering for investors and it is always welcome to see a fund that is transparent about what it does and how it aims to make money. We rate this as a core holding for a diversified investment fund.
Smithson Investment share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Smithson I..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201202 04:31:14